NQF Endorses Additional Infectious Disease Measures 

MAR 06, 2013

CONTACT: Erin Weireter

NQF Endorses Additional Infectious Disease Measures

Washington, DC - the National Quality Forum (NQF) Board of Directors has endorsed two additional infectious disease measures addressing severe sepsis and sepsis shock, and testing for chronic hepatitis C. These measures were originally evaluated as part of NQF’s infectious disease measure endorsement project, which had 14 measures endorsed in January.

NQF is a voluntary consensus standards-setting organization. Any party may request reconsideration of the endorsed quality measures listed below by submitting an appeal no later than April 4 (to submit an appeal, go to the NQF Measure Database). For an appeal to be considered, the notification must include information clearly demonstrating that the appellant has interests directly and materially affected by the NQF-endorsed recommendations and that the NQF decision has had (or will have) an adverse effect on those interests.

Measures List 

  • 0500: Severe sepsis and septic shock: Management bundle (Henry Ford Hospital)
  • 0393: Hepatitis C: Testing for chronic hepatitis C – Confirmation of hepatitis C viremia (AMA-PCPI)

NQF operates under a three-part mission to improve the quality of American healthcare by: 

  • building consensus on national priorities and goals for performance improvement and working in partnership to achieve them;
  • endorsing national consensus standards for measuring and publicly reporting on performance; and
  • promoting the attainment of national goals through education and outreach programs.